Status:
RECRUITING
MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)
Lead Sponsor:
University of Florence
Collaborating Sponsors:
Tubingen University Hospital
Maria Sklodowska-Curie National Research Institute of Oncology
Conditions:
Melanoma of Skin
Eligibility:
All Genders
Up to 30 years
Brief Summary
The aim of this study is to investigate a type of skin cancer, also known as melanoma, in children, adolescents, and young adults, who will be referred to as CAYA patients in this project. The need fo...
Detailed Description
The Mol-Mel study will focus on different tasks and for each task different investigations will be carried out: * Standardization and tissue quality control: The quality of the samples will then be d...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- adolescent and childhood patients (\< 20 years) or young adults (\< 30 years)
- histologically confirmed diagnosis of melanoma or intermediate/ambiguous melanocytic neoplasm (i.e., melanocytomas, SAMPUS, IAMPUS and MELTUMP according to WHO classification)
- Exclusion criteria:
- adult patients (\> 30 years of age)
- patients without histologically confirmed diagnosis of melanoma or intermediate/ambiguous melanocytic neoplasm
Exclusion
Key Trial Info
Start Date :
April 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06602648
Start Date
April 17 2024
End Date
November 1 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florence
Florence, Italy, Italy, 50139